Transcript signatures that predict outcome and identify targetable pathways in MYCN‐amplified neuroblastoma
Robin Hallett(Hospital for Sick Children), Meredith S. Irwin(University of Toronto)
Cited by 17
Related Papers
Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
|PLoS ONE|2012|93
Eukaryotic Translation Elongation Factor 1-Alpha 1 Inhibits p53 and p73 Dependent Apoptosis and Chemotherapy Sensitivity
|PLoS ONE|2013|70
SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma
|Cancer Research Communications|2023|9
DNA Damage Response Deficiency Enhances Neuroblastoma Progression and Sensitivity to Combination PARP and ATR Inhibition
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0